The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Terlipressin for Injection Market Research Report 2024

Global Terlipressin for Injection Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1738309

No of Pages : 105

Ask Your Query

Synopsis
Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.
Global Terlipressin for Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Terlipressin for Injection market research.

Key manufacturers engaged in the Terlipressin for Injection industry include Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure and Criticine Care, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Terlipressin for Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Terlipressin for Injection market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Terlipressin for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Ferring Pharmaceuticals
  • Ranbaxy UK Ltd
  • TAJ LIFE SCIENCES
  • Mallinckrodt plc
  • EVER Pharma
  • Alliance Pharmaceuticals
  • Serum Institute of India Pvt. Ltd
  • Biovenice Criticure
  • Criticine Care
  • Integrated Laboratories Pvt Ltd
  • Hybio Pharmaceutical Co., Ltd
  • Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
  • Hangzhou Ausia Biological Technology Company, Ltd
  • Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
  • Hainan General Sanyang Pharmaceutical Co., Ltd

Segment by Type

  • Lumps
  • Powder

Segment by Application

  • Internal Medicine Application
  • surgical application
  • Intensive Care Unit (ICU) Applications

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Terlipressin for Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Terlipressin for Injection Market Overview
1.1 Product Overview and Scope of Terlipressin for Injection
1.2 Terlipressin for Injection Segment by Type
1.2.1 Global Terlipressin for Injection Market Value Comparison by Type (2023-2029)
1.2.2 Lumps
1.2.3 Powder
1.3 Terlipressin for Injection Segment by Application
1.3.1 Global Terlipressin for Injection Market Value by Application: (2023-2029)
1.3.2 Internal Medicine Application
1.3.3 surgical application
1.3.4 Intensive Care Unit (ICU) Applications
1.4 Global Terlipressin for Injection Market Size Estimates and Forecasts
1.4.1 Global Terlipressin for Injection Revenue 2018-2029
1.4.2 Global Terlipressin for Injection Sales 2018-2029
1.4.3 Global Terlipressin for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Terlipressin for Injection Market Competition by Manufacturers
2.1 Global Terlipressin for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Terlipressin for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Terlipressin for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Terlipressin for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Terlipressin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terlipressin for Injection, Product Type & Application
2.7 Terlipressin for Injection Market Competitive Situation and Trends
2.7.1 Terlipressin for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Terlipressin for Injection Players Market Share by Revenue
2.7.3 Global Terlipressin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terlipressin for Injection Retrospective Market Scenario by Region
3.1 Global Terlipressin for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Terlipressin for Injection Global Terlipressin for Injection Sales by Region: 2018-2029
3.2.1 Global Terlipressin for Injection Sales by Region: 2018-2023
3.2.2 Global Terlipressin for Injection Sales by Region: 2024-2029
3.3 Global Terlipressin for Injection Global Terlipressin for Injection Revenue by Region: 2018-2029
3.3.1 Global Terlipressin for Injection Revenue by Region: 2018-2023
3.3.2 Global Terlipressin for Injection Revenue by Region: 2024-2029
3.4 North America Terlipressin for Injection Market Facts & Figures by Country
3.4.1 North America Terlipressin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Terlipressin for Injection Sales by Country (2018-2029)
3.4.3 North America Terlipressin for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Terlipressin for Injection Market Facts & Figures by Country
3.5.1 Europe Terlipressin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Terlipressin for Injection Sales by Country (2018-2029)
3.5.3 Europe Terlipressin for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terlipressin for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Terlipressin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Terlipressin for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Terlipressin for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Terlipressin for Injection Market Facts & Figures by Country
3.7.1 Latin America Terlipressin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Terlipressin for Injection Sales by Country (2018-2029)
3.7.3 Latin America Terlipressin for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Terlipressin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Terlipressin for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Terlipressin for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Terlipressin for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terlipressin for Injection Sales by Type (2018-2029)
4.1.1 Global Terlipressin for Injection Sales by Type (2018-2023)
4.1.2 Global Terlipressin for Injection Sales by Type (2024-2029)
4.1.3 Global Terlipressin for Injection Sales Market Share by Type (2018-2029)
4.2 Global Terlipressin for Injection Revenue by Type (2018-2029)
4.2.1 Global Terlipressin for Injection Revenue by Type (2018-2023)
4.2.2 Global Terlipressin for Injection Revenue by Type (2024-2029)
4.2.3 Global Terlipressin for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Terlipressin for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Terlipressin for Injection Sales by Application (2018-2029)
5.1.1 Global Terlipressin for Injection Sales by Application (2018-2023)
5.1.2 Global Terlipressin for Injection Sales by Application (2024-2029)
5.1.3 Global Terlipressin for Injection Sales Market Share by Application (2018-2029)
5.2 Global Terlipressin for Injection Revenue by Application (2018-2029)
5.2.1 Global Terlipressin for Injection Revenue by Application (2018-2023)
5.2.2 Global Terlipressin for Injection Revenue by Application (2024-2029)
5.2.3 Global Terlipressin for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Terlipressin for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ferring Pharmaceuticals
6.1.1 Ferring Pharmaceuticals Corporation Information
6.1.2 Ferring Pharmaceuticals Description and Business Overview
6.1.3 Ferring Pharmaceuticals Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ferring Pharmaceuticals Terlipressin for Injection Product Portfolio
6.1.5 Ferring Pharmaceuticals Recent Developments/Updates
6.2 Ranbaxy UK Ltd
6.2.1 Ranbaxy UK Ltd Corporation Information
6.2.2 Ranbaxy UK Ltd Description and Business Overview
6.2.3 Ranbaxy UK Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ranbaxy UK Ltd Terlipressin for Injection Product Portfolio
6.2.5 Ranbaxy UK Ltd Recent Developments/Updates
6.3 TAJ LIFE SCIENCES
6.3.1 TAJ LIFE SCIENCES Corporation Information
6.3.2 TAJ LIFE SCIENCES Description and Business Overview
6.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TAJ LIFE SCIENCES Terlipressin for Injection Product Portfolio
6.3.5 TAJ LIFE SCIENCES Recent Developments/Updates
6.4 Mallinckrodt plc
6.4.1 Mallinckrodt plc Corporation Information
6.4.2 Mallinckrodt plc Description and Business Overview
6.4.3 Mallinckrodt plc Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mallinckrodt plc Terlipressin for Injection Product Portfolio
6.4.5 Mallinckrodt plc Recent Developments/Updates
6.5 EVER Pharma
6.5.1 EVER Pharma Corporation Information
6.5.2 EVER Pharma Description and Business Overview
6.5.3 EVER Pharma Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 EVER Pharma Terlipressin for Injection Product Portfolio
6.5.5 EVER Pharma Recent Developments/Updates
6.6 Alliance Pharmaceuticals
6.6.1 Alliance Pharmaceuticals Corporation Information
6.6.2 Alliance Pharmaceuticals Description and Business Overview
6.6.3 Alliance Pharmaceuticals Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Alliance Pharmaceuticals Terlipressin for Injection Product Portfolio
6.6.5 Alliance Pharmaceuticals Recent Developments/Updates
6.7 Serum Institute of India Pvt. Ltd
6.6.1 Serum Institute of India Pvt. Ltd Corporation Information
6.6.2 Serum Institute of India Pvt. Ltd Description and Business Overview
6.6.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Serum Institute of India Pvt. Ltd Terlipressin for Injection Product Portfolio
6.7.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
6.8 Biovenice Criticure
6.8.1 Biovenice Criticure Corporation Information
6.8.2 Biovenice Criticure Description and Business Overview
6.8.3 Biovenice Criticure Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Biovenice Criticure Terlipressin for Injection Product Portfolio
6.8.5 Biovenice Criticure Recent Developments/Updates
6.9 Criticine Care
6.9.1 Criticine Care Corporation Information
6.9.2 Criticine Care Description and Business Overview
6.9.3 Criticine Care Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Criticine Care Terlipressin for Injection Product Portfolio
6.9.5 Criticine Care Recent Developments/Updates
6.10 Integrated Laboratories Pvt Ltd
6.10.1 Integrated Laboratories Pvt Ltd Corporation Information
6.10.2 Integrated Laboratories Pvt Ltd Description and Business Overview
6.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Integrated Laboratories Pvt Ltd Terlipressin for Injection Product Portfolio
6.10.5 Integrated Laboratories Pvt Ltd Recent Developments/Updates
6.11 Hybio Pharmaceutical Co., Ltd
6.11.1 Hybio Pharmaceutical Co., Ltd Corporation Information
6.11.2 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Description and Business Overview
6.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Product Portfolio
6.11.5 Hybio Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
6.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Corporation Information
6.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Description and Business Overview
6.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Product Portfolio
6.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments/Updates
6.13 Hangzhou Ausia Biological Technology Company, Ltd
6.13.1 Hangzhou Ausia Biological Technology Company, Ltd Corporation Information
6.13.2 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Description and Business Overview
6.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Product Portfolio
6.13.5 Hangzhou Ausia Biological Technology Company, Ltd Recent Developments/Updates
6.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
6.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Corporation Information
6.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Description and Business Overview
6.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Product Portfolio
6.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments/Updates
6.15 Hainan General Sanyang Pharmaceutical Co., Ltd
6.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Corporation Information
6.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Description and Business Overview
6.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Product Portfolio
6.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terlipressin for Injection Industry Chain Analysis
7.2 Terlipressin for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terlipressin for Injection Production Mode & Process
7.4 Terlipressin for Injection Sales and Marketing
7.4.1 Terlipressin for Injection Sales Channels
7.4.2 Terlipressin for Injection Distributors
7.5 Terlipressin for Injection Customers
8 Terlipressin for Injection Market Dynamics
8.1 Terlipressin for Injection Industry Trends
8.2 Terlipressin for Injection Market Drivers
8.3 Terlipressin for Injection Market Challenges
8.4 Terlipressin for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock